| Sep 19 |
Abbott Stock Hurt by Macroeconomic Issues & FX Headwind
|
| Sep 17 |
AxoGen: An Intriguing Growth Story
|
| Sep 11 |
AxoGen, Inc. (NASDAQ:AXGN): Are Analysts Optimistic?
|
| Sep 6 |
Axogen completes marketing submission for Avance Nerve Graft
|
| Sep 6 |
Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®
|
| Sep 4 |
AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?
|
| Sep 3 |
Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)
|
| Aug 30 |
What Makes AxoGen (AXGN) a Strong Momentum Stock: Buy Now?
|
| Aug 23 |
Wall Street Analysts See a 25.51% Upside in AxoGen (AXGN): Can the Stock Really Move This High?
|
| Aug 19 |
AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run?
|
